Details of the SBP
| General Information of Synthetic Binding Protein (SBP) (ID: SBP001703) | ||||||
|---|---|---|---|---|---|---|
| SBP Name |
scFv anti-BHL clone B1
|
|||||
| Synonyms |
scFv B1
|
|||||
| Design Method | Traditional methods (Site-directed mutagenesis and/or Directed evolution) | |||||
| Expression System | Escherichia coli BL21 | |||||
| Selection Method | Phage display | |||||
| Highest Status | Research | |||||
| SBP Sequence |
>VH CDR3
FWHQYS >VL CDR3 QQKSDEPQ |
|||||
| Protein Scaffold Information of This SBP | ||||||
|---|---|---|---|---|---|---|
| Scaffold ID | PS057 | [1] | ||||
| Scaffold Name | scFv | |||||
| Scaffold Class | Antibody fragment | |||||
| Fold Type | Beta-Sheets + Loops | |||||
| Binding Target(s) of This SBP (BTS) |
|---|
| BTS Name | Details | Mechanism | Application | Affinity | Research Organization | Ref |
|---|---|---|---|---|---|---|
| T-cell surface glycoprotein CD3 | Binder | Ovarian cancer [ICD-11: 2C73.Z] | N.A. | Chinese Academy of Sciences | [1] | |
| Anti-ovarian carcinoma bispecific Antibody | Binder | Ovarian cancer [ICD-11: 2C73.Z] | N.A. | Chinese Academy of Sciences | [1] | |